Mega Lifesciences Cal-D Plus

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

zinc sulfate monohydrate, Quantity: 20.6 mg (Equivalent: zinc, Qty 7.5 mg); cupric sulfate pentahydrate, Quantity: 3.928 mg (Equivalent: copper, Qty 1 mg); manganese sulfate monohydrate, Quantity: 5.539 mg (Equivalent: manganese, Qty 1.8 mg); dried magnesium sulfate, Quantity: 317.46 mg (Equivalent: magnesium, Qty 40 mg); borax, Quantity: 2.205 mg (Equivalent: boron, Qty 0.25 mg); calcium carbonate, Quantity: 1.5 g (Equivalent: calcium, Qty 600 mg); colecalciferol, Quantity: 0.005 mg

Available from:

Mega Lifesciences (Australia) Pty Ltd

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: pregelatinised maize starch; sodium starch glycollate; magnesium stearate; maltodextrin; colloidal anhydrous silica; sodium lauryl sulfate; povidone; titanium dioxide; brilliant blue FCF; sunset yellow FCF; purified talc; allura red AC; polyvinyl alcohol; macrogol 3350; lecithin; maize starch; Acacia; silicon dioxide; dl-alpha-tocopherol; sucrose; medium chain triglycerides

Administration route:

Oral

Therapeutic indications:

Maintain/support bone health ; Maintain/support bone strength ; A diet deficient in calcium can lead to osteoporosis in later life. Calcium may help prevent osteoporosis when dietary intake is inadequate ; Vitamin D helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life

Product summary:

Visual Identification: ;

Authorization status:

Listed